HOUSTON – A vaccine that was developed at the University of Houston to prevent fentanyl deaths has been licensed by a new medical startup and will head for human clinical trials, according the the university.
OVAX Inc. raised $10 million to commercialize research from the lab of Colin Haile, a…
[ad_2]
Source link
